# An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

> **NCT00263796** · PHASE1 · COMPLETED · sponsor: **Anagnostou, Evdokia, M.D.** · enrollment: 16 (actual)

## Conditions studied

- Autism

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00263796
- **Lead sponsor:** Anagnostou, Evdokia, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2010-10
- **Final completion:** 2012-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263796, "An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00263796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*